Geschäft · 22.10.20261 Min. Lesezeit
Granata Bio Completes Screening in Phase III GRACE Study of GB-hMG
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
Pivotal IVF study advances into pregnancy follow-up, with the first GRACE baby expected by year-end BOSTON, Oct. 22, 2026 — Granata Bio Corporation, a biopharmaceutical company dedicated to advancing rep…